Insights
One specific point per article, drawn from what several experts said across different podcasts: where they agree, where they don't, and what to do with it. Every claim links back to the episode it came from.
Short on time? Cheat sheets and flashcards for the insights.
FiltersHormonesDopamine and MotivationLongevityClear
Pick as many as you like: any of them matches within a group.
105 insights, page 1 of 5
Gambling's grip: an addiction researcher, a reward scientist and a comic's family
Keith Humphreys describes industries built on addiction, especially gambling, Robert Malenka ties gambling and social media to intermittent reward, and comic Adrienne Iapalucci tells her family's gambling story. Together they show gambling as a reward-system problem with real costs to families, not a harmless pastime.
L-tyrosine, mucuna and food: the dopamine supplements Huberman discusses, behaviors first
Across several episodes Huberman names amino acids like tyrosine, L-tyrosine supplements and mucuna pruriens as levers on dopamine, alongside behavioral tools such as cold exposure, while putting behaviors before nutrition, supplements and drugs. Knowing where these compounds sit in that order helps readers avoid reaching for a pill before the basics.
Vague goals fail: define the actions, the numbers and a range
Mel Robbins' goal episodes call for measurable goals with a range rather than general wishes, and Huberman's goal toolkits ask for specific verbs, quantified actions and concrete plans. A goal you can count is one you can act on and check, which is where most good intentions break down.
Truth telling and community: what Lembke and Humphreys say sustains recovery
Anna Lembke's conversations and book stress radical honesty, making amends and recovery communities, while Keith Humphreys walks through how people change and the role of groups like AA. Recovery from compulsive use is described as a social and moral practice as much as a chemical reset, which gives people concrete steps after the first weeks of abstinence.
The pill's trade-offs: benefits, underappreciated risks and what it means for fertility
Sharon Malone walks through birth control's benefits, its myths and the return of the rhythm method, Sara Gottfried weighs real benefits against underappreciated risks and discusses oral contraceptives and the copper IUD, Natalie Crawford explains what birth control does and does not do to fertility, Kyle Gillett discusses oral contraceptives alongside PCOS, Stacy Sims covers birth control with iron and blood tests, Rena Malik takes up contraception, and Andrew Huberman describes how the pill interacts with odor and ovulation in attraction. Comparing these views helps women weigh contraception choices with the full set of effects in mind.
PCOS beyond the ovaries: insulin, inositol, testing and a new name
Sara Gottfried ties PCOS to insulin and the power of continuous glucose monitors, Kyle Gillett discusses inositol for PCOS, Sharon Malone explains why PCOS is now being called PMOS, Natalie Crawford explains the condition in her tour of female reproductive health, and Stacy Sims covers PCOS alongside iron and blood tests. Hearing these explanations together helps women understand what the diagnosis involves and which questions to raise about insulin and testing.
Why women's hormone problems get missed: blind spots in medicine and research
Amy Shah describes a knowledge gap built into medicine, Rachel Rubin a gap in medical training, Mary Claire Haver a medical blind spot covering a third of women's lives and a research gap in women's health, and Sharon Malone the one continuous story of women's hormones that nobody tells. Seeing the same gap described by several doctors from different specialties explains why so many women's hormonal symptoms go unrecognized.
Cancer risk you can change: screening, metabolism, alcohol and immune defenses
Jason Fung describes cancer as a seed that needs the right soil, Peter Attia and Chris Thompson argue for earlier and better screening, and immunologists explain why tumors slip past the body's defenses. Together they show which parts of cancer risk a person can act on and where the experts still disagree.
Never too late: what starting to train after 50 delivers
Vonda Wright rejects the idea that decline is inevitable, Layne Norton and Pavel Tsatsouline explain how to lift safely later in life, and performers in their seventies describe getting stronger than they were at 50. Their accounts answer the common worry that the window for building strength has already closed.
Turning Back the Clock: Age Reversal, Escape Velocity and What Is Actually Proven
David Sinclair reports that a cellular reprogramming therapy has entered its first human trial, Ray Kurzweil forecasts more than a year of added life expectancy per year by the end of the decade, and Nick Bostrom and Michael Levin add what ending aging would demand and another biological route to it. The sources contain no outside critic of these claims, so this piece sorts each one by its evidence: shown in animals, shown in human cells, under test in people, or still a prediction.
Your mouth is a health organ: oral bacteria, fluoride and whole-body disease
Dentist Staci Whitman and Huberman's oral health episode treat the mouth as a living ecosystem that teeth repair within, and warn that harsh mouthwash and constant snacking damage it, while James Nestor ties shrinking jaws to breathing problems. Looking after the mouth turns out to protect far more than teeth.
Erectile dysfunction as an early warning: blood flow, not hormones
Urologists Michael Eisenberg and Rena Malik say most erectile problems come from blood vessels and the pelvic floor and often appear before heart disease does, and Kelly Starrett and Kyle Gillett add the movement and lifestyle side. Men who treat it as a health signal get a chance to fix the cause early.
Growth hormone: the youth hormone that may not lengthen life
Clinics offer growth hormone and drugs that release it to restore youthful muscle and skin, and Kyle Gillett and Craig Koniver describe using them, yet David Sinclair notes that lower growth signaling goes with longer life and Huberman lists the risks of injecting it. The contrast shows why feeling younger and living longer are not always the same goal.
Reversing type 2 diabetes: what Fung, Attia and Means say works
Jason Fung calls type 2 diabetes a problem of too much sugar stored in the body, Peter Attia describes the factors behind it and cases of remission, and Casey Means explains the early blood markers. They agree the condition can often be pushed back with food timing, weight loss and movement, which changes how patients should think about a diagnosis.
Is fruit a problem? Fructose, fiber and the fatty liver question
Robert Lustig and the Means siblings single out fructose as uniquely harmful to the liver, yet Jason Fung, Peter Attia and David Sinclair each draw a different line between whole fruit, juice and added sugar. Sorting out their positions tells readers what to cut and what to keep eating.
Use it or lose it: novelty and mental challenge protect the aging brain
Tommy Wood, Mark D'Esposito, Alan Castel and Charan Ranganath all say the brain stays adaptable when it keeps meeting new and demanding tasks, and that routine alone lets it slide. This gives people a second lever against cognitive decline that works alongside exercise and sleep.
Artificial Sweeteners: Harmless Swap or Hidden Problem for Gut and Appetite?
Layne Norton treats non-sugar sweeteners as a useful way to cut calories, Robert Lustig and Justin Sonnenburg see risks to insulin and the microbiome, and Peter Attia and Andrew Huberman end up in the middle with limited use. The sources show what evidence each position leans on; gastroenterologist Chris Thompson was asked the question, but his answer did not survive in the available transcript.
Narrow your visual focus to make goals feel closer
Emily Balcetis's research on elite runners and Huberman's goal episodes show that literally focusing the eyes on a target makes it feel closer and effort feel easier. It's a low-effort, science-backed trick for staying on task.
When motivation disappears: apathy, depression and what helps
Masud Husain describes apathy as a distinct brain state, Huberman explains anhedonia in depression and why behavioral tools are hard to use, and the ketamine episode shows new ways to restore drive. It helps readers tell ordinary low motivation from a condition that needs care.
Psychedelics for addiction: promise, limits and caution
Matthew Johnson reports psilocybin trials helping addiction, Anna Lembke sees promise but urges caution, and Huberman's MDMA episode weighs benefits against crashes and neurotoxicity. The field offers hope for compulsive behaviors but isn't a shortcut.
11 minutes cold, 57 minutes heat: the weekly dose for metabolic health
Susanna Søberg's winter swimmer research, Huberman's cold and heat episodes and Rhonda Patrick converge on modest weekly doses of cold and sauna for brown fat, insulin sensitivity and heart health, ending on cold. It turns vague advice into a specific, achievable target.
ApoB and blood pressure: the fixable numbers behind heart disease
Peter Attia calls blood pressure under-diagnosed and apoB a causal driver to treat early, Layne Norton changed his mind on LDL, and Casey Means lists the blood tests everyone should know. Cardiovascular disease is the top killer, and these are measurable and modifiable.
Don't find your passion, build it through progress
Anna Lembke urges letting go of finding your passion, Masud Husain describes passion emerging from learning and perseverance, and Tony Hawk's 40 years of progression show how drive grows from getting better. Passion is usually the result of effort, not the prerequisite.
Exercise and immunity: moderate helps, extreme hurts
Roger Seheult's J-curve and Huberman's cold, flu and immune episodes agree that regular moderate exercise strengthens immunity while very intense bouts can temporarily weaken it. It helps active people train smart during cold and flu season.